#GynCSM Transcript

Healthcare social media transcript of the #GynCSM hashtag.
().
See #GynCSM Influencers/Analytics.

ProfileTweet
GYN Cancer | #GYNCSM @gyncsm
Welcome to #gyncsm - a passionate community of gynecologic cancer survivors, caregivers, advocates and health care providers.
GYN Cancer | #GYNCSM @gyncsm
Our community co-moderators are @womenofteal @btrfly12 Our community healthcare moderators are @ShannonWestin @temkins @journeycancer and our mental health moderator @DrBeckerSchutte #gyncsm
Dee Sparacio @womenofteal
#gyncsm
GYN Cancer | #GYNCSM @gyncsm
We start out with brief intro’s - Please take a moment to introduce yourself. :) #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: Welcome to #gyncsm - a passionate community of gynecologic cancer survivors, caregivers, advocates and health care providers.
Dee Sparacio @womenofteal
RT @gyncsm: Our community co-moderators are @womenofteal @btrfly12 Our community healthcare moderators are @ShannonWestin @temkins @journeycancer and our mental health moderator @DrBeckerSchutte #gyncsm
Jillosopher, BSN, RN @jillosopher
Hello #gyncsm Endometrial cancer survivor. Dx'ed Jan 2017. stage 3a endometrioid.
Dee Sparacio @womenofteal
@jillosopher So happy you could join us Jill. #gyncsm
Jillosopher, BSN, RN @jillosopher
I'm also a nurse, not practicing yet, but looking for work. :) #gyncsm
Tobey @BRCAinfo
Hi 👋 Happy healthy holiday season #gyncsm
Christina Lizaso @btrfly12
Christina Lizaso – passionate re: community engagement and cancer. I’ll be moderating as @gyncsm today. #gyncsm
Dee Sparacio @womenofteal
Dee here! Dx #ovca Stage3B 2005, OC research advocate, blogger & co-moderator #gyncsm
Rick Boulay,MD @journeycancer
RT @gyncsm: Welcome to #gyncsm - a passionate community of gynecologic cancer survivors, caregivers, advocates and health care providers.
Dee Sparacio @womenofteal
@BRCAinfo Hi there Tobey. Glad you are here tonight. #gyncsm
Jillosopher, BSN, RN @jillosopher
@womenofteal Thanks, Dee. Glad to be here. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
If you prefer to listen-only during the chat, we'd love for you to tweet "#gyncsm" when you join - just to let us know you are here.
Rick Boulay,MD @journeycancer
Good evening everyone. Rick Boulay GYN oncologist Bethlehem Pennsylvania #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Please continue intro's and welcomes - we'll start in w/ a couple "ground rules" and tips. #gyncsm
Tobey @BRCAinfo
@womenofteal Thank you. Always nice to be here & show support. #gyncsm
Dee Sparacio @womenofteal
@journeycancer Hi Rick. Hope you are doing well. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
The #gyncsm chat promotes community in a public forum. Learn more about risks/benefits: https://t.co/TipZUv1jQy
Christine (Cissy) White @healWRITEnow
Introducing myself. Writer. Advocate about how adversity in childhood impacts adult health. Getting chemo for ovarian cancer diagnosed a few mos. who. #gyncsm
Jillosopher, BSN, RN @jillosopher
@journeycancer Hi Rick. Good to see you. #gyncsm
Dee Sparacio @womenofteal
#gyncsm tagged resources and referrals are not a substitute for speaking with your doctor who understands your needs and history.
Christina Lizaso @btrfly12
#gyncsm
Jillosopher, BSN, RN @jillosopher
@BRCAinfo @womenofteal Hi Toby. #gyncsm
Dee Sparacio @womenofteal
@healWRITEnow Welcome to our community and our chat. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Are you new to tweet chats? Follow hashtag #gyncsm and include it in every tweet during the next hour to engage with others about this topic.
Dee Sparacio @womenofteal
@tanyaltee Glad to see you tonight! #gyncsm
Dee Sparacio @womenofteal
Remember - Twitter is an open social network and posts are public. Use a Direct Messages to exchange email addresses/personal info #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Lovely group gathering for our last chat of 2019. We also welcome all those “listening in”. You can always DM or email us with questions/comments after the chat is over. https://t.co/oAfi7Me49e #gyncsm
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
Hello friends. I'm Shereese here in Maryland #gyncsm https://t.co/XRbYpBFhbN
Dee Sparacio @womenofteal
RT @gyncsm: Lovely group gathering for our last chat of 2019. We also welcome all those “listening in”. You can always DM or email us with questions/comments after the chat is over. https://t.co/oAfi7Me49e #gyncsm
Dee Sparacio @womenofteal
@ShereesePubHlth Waving Hi . Thanks for joining Shereese. #gyncsm
Tobey @BRCAinfo
@jillosopher @womenofteal Hiya back at you! Thanks for the shout out #gyncsm
Dee Sparacio @womenofteal
Thank you to all who have tweeted during the past month with the #gyncsm hashtag and those who RT'd about this chat #gyncsm
Lisa M Guzzardi, RN @LguzzardiM
Happy Holidays #gyncsm from NY! #HereditaryCancer Patient advocate here & global journal club founder via FB. 🎄🎁 🕎 🕯
Dee Sparacio @womenofteal
@LguzzardiM Hi Lisa - Happy Holidays to you too. Thanks for joining us. #gyncsm
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
@jillosopher Hello #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Tonight on #gyncsm our chat will be a little different as we share about the #gyncsm Survey Results and then have our 4th "open mic" discussion vs. having set questions around a central topic.
Dee Sparacio @womenofteal
RT @gyncsm: Tonight on #gyncsm our chat will be a little different as we share about the #gyncsm Survey Results and then have our 4th "open mic" discussion vs. having set questions around a central topic.
Tobey @BRCAinfo
RT @gyncsm: Tonight on #gyncsm our chat will be a little different as we share about the #gyncsm Survey Results and then have our 4th "open mic" discussion vs. having set questions around a central topic.
GYN Cancer | #GYNCSM @gyncsm
You can find information about tonight’s chat on our #gyncsm blog page: https://t.co/SRGaQiRCKN
Dee Sparacio @womenofteal
RT @gyncsm: You can find information about tonight’s chat on our #gyncsm blog page: https://t.co/SRGaQiRCKN
GYN Cancer | #GYNCSM @gyncsm
We’re going to take the first few minutes of tonight’s chat to share 5 slides with some of the results of our 2019 #gyncsm Community Survey...
Dee Sparacio @womenofteal
RT @gyncsm: We’re going to take the first few minutes of tonight’s chat to share 5 slides with some of the results of our 2019 #gyncsm Community Survey...
GYN Cancer | #GYNCSM @gyncsm
Survey Results: Who responded to the 2019 #gyncsm community survey? [graphic] https://t.co/DLjYUKbbgk
Dee Sparacio @womenofteal
Happy to share 5 graphics with results from our #gyncsm survey. Who responded?
Christina Lizaso @btrfly12
Between chats on the hashtag and on some chats themselves we have a lot of healthcare folks. It was nice to see this % of patients/survivors took the survey and are impacted by this community. #gyncsm
Dee Sparacio @womenofteal
RT @btrfly12: Between chats on the hashtag and on some chats themselves we have a lot of healthcare folks. It was nice to see this % of patients/survivors took the survey and are impacted by this community. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Survey Results: How did those who responded to the survey interact in the #gyncsm community? [graphic] https://t.co/EaytHMfJT1
Dee Sparacio @womenofteal
RT @gyncsm: Survey Results: Survey Results: How did those who responded to the survey interact in the #gyncsm community? [graphic] https://t.co/EaytHMfJT1
Christina Lizaso @btrfly12
RT @gyncsm: Survey Results: Survey Results: How did those who responded to the survey interact in the #gyncsm community? [graphic] https://t.co/EaytHMfJT1
Rick Boulay,MD @journeycancer
RT @gyncsm: Survey Results: Survey Results: How did those who responded to the survey interact in the #gyncsm community? [graphic] https://t.co/EaytHMfJT1
Enlightening Results 💡 @GraceCordovano
RT @btrfly12: Between chats on the hashtag and on some chats themselves we have a lot of healthcare folks. It was nice to see this % of patients/survivors took the survey and are impacted by this community. #gyncsm
Enlightening Results 💡 @GraceCordovano
RT @gyncsm: Survey Results: Survey Results: How did those who responded to the survey interact in the #gyncsm community? [graphic] https://t.co/EaytHMfJT1
Enlightening Results 💡 @GraceCordovano
RT @gyncsm: Tonight on #gyncsm our chat will be a little different as we share about the #gyncsm Survey Results and then have our 4th "open mic" discussion vs. having set questions around a central topic.
Jillosopher, BSN, RN @jillosopher
@LoriAdelson2 @gyncsm Hi Lori! Welcome. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Survey Results: What was learned and used from #gyncsm by those who responded to the survey? [graphic] Those on tonight - What would you add to the list? https://t.co/nobnE2hs1R
Dee Sparacio @womenofteal
@gyncsm Interesting that there are those who follow the chat but don't tweet. Even if you don't participate let us know you are here by tweeting #gyncsm
Tobey @BRCAinfo
@LoriAdelson2 @gyncsm Welcome to #gyncsm
Dee Sparacio @womenofteal
@LoriAdelson2 @gyncsm Hi Lori, Thanks for joining us. #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: Survey Results: Survey Results: What was learned and used from #gyncsm by those who responded to the survey? [graphic] Those on tonight - What would you add to the list? https://t.co/nobnE2hs1R
Rick Boulay,MD @journeycancer
RT @gyncsm: Survey Results: Survey Results: What was learned and used from #gyncsm by those who responded to the survey? [graphic] Those on tonight - What would you add to the list? https://t.co/nobnE2hs1R
GYN Cancer | #GYNCSM @gyncsm
Survey Results: What were the important topics covered by #gyncsm in 2019? [graphic] https://t.co/oUL4ivOrJm
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
RT @gyncsm: Survey Results: Survey Results: What was learned and used from #gyncsm by those who responded to the survey? [graphic] Those on tonight - What would you add to the list? https://t.co/nobnE2hs1R
Rick Boulay,MD @journeycancer
RT @gyncsm: Survey Results: Survey Results: What were the important topics covered by #gyncsm in 2019? [graphic] https://t.co/oUL4ivOrJm
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
RT @btrfly12: Between chats on the hashtag and on some chats themselves we have a lot of healthcare folks. It was nice to see this % of patients/survivors took the survey and are impacted by this community. #gyncsm
Sarah Temkin @temkins
RT @gyncsm: Survey Results: Survey Results: What was learned and used from #gyncsm by those who responded to the survey? [graphic] Those on tonight - What would you add to the list? https://t.co/nobnE2hs1R
Dee Sparacio @womenofteal
@gyncsm I've shared a few #gyncsm blog posts to a closed Facebook group
Christina Lizaso @btrfly12
@gyncsm You can find the summary blog posts about all our topics on the #gyncsm blog. The summary contains selected tweets plus a link to the full transcript and all the links shared during the chat are at the bottom. https://t.co/Yjl2PARkex
Dee Sparacio @womenofteal
RT @gyncsm: Survey Results: Survey Results: What were the important topics covered by #gyncsm in 2019? [graphic] https://t.co/oUL4ivOrJm
Dee Sparacio @womenofteal
RT @btrfly12: @gyncsm You can find the summary blog posts about all our topics on the #gyncsm blog. The summary contains selected tweets plus a link to the full transcript and all the links shared during the chat are at the bottom. https://t.co/Yjl2PARkex
Jillosopher, BSN, RN @jillosopher
RT @btrfly12: @gyncsm You can find the summary blog posts about all our topics on the #gyncsm blog. The summary contains selected tweets plus a link to the full transcript and all the links shared during the chat are at the bottom. https://t.co/Yjl2PARkex
Christina Lizaso @btrfly12
#gyncsm :
Rachel Pozzar, PhD, RN @RPozzar
RT @gyncsm: Survey Results: Survey Results: What were the important topics covered by #gyncsm in 2019? [graphic] https://t.co/oUL4ivOrJm
Tobey @BRCAinfo
RT @btrfly12: @gyncsm You can find the summary blog posts about all our topics on the #gyncsm blog. The summary contains selected tweets plus a link to the full transcript and all the links shared during the chat are at the bottom. https://t.co/Yjl2PARkex
GYN Cancer | #GYNCSM @gyncsm
Last one: Survey Results: How can #gyncsm do better in the future? [graphic] https://t.co/jaw7XY1eDC
Lisa M Guzzardi, RN @LguzzardiM
@gyncsm Interesting side note that clinical trials are missing from the list. Unimportant? Unnoticed ? Unpopular? #gyncsm
Dee Sparacio @womenofteal
@healWRITEnow @gyncsm We have genetic counselors and other health care providers join in too. If you add #gyncsm to your tweet everyone following the hashtag and this chat can see your responses.
Dee Sparacio @womenofteal
RT @gyncsm: Last one: Survey Results: How can #gyncsm do better in the future? [graphic] https://t.co/jaw7XY1eDC
Christina Lizaso @btrfly12
Thanks so much to everyone who filled out the survey. We are using the topic feedback as we finalize our 2020 chats. FYI - We'll be taking off March/June/October as we did in 2019. #gyncsm
Sarah Temkin @temkins
RT @gyncsm: Last one: Survey Results: How can #gyncsm do better in the future? [graphic] https://t.co/jaw7XY1eDC
Sarah Temkin @temkins
RT @gyncsm: Survey Results: Survey Results: How did those who responded to the survey interact in the #gyncsm community? [graphic] https://t.co/EaytHMfJT1
Sarah Temkin @temkins
RT @btrfly12: Between chats on the hashtag and on some chats themselves we have a lot of healthcare folks. It was nice to see this % of patients/survivors took the survey and are impacted by this community. #gyncsm
Christina Lizaso @btrfly12
@LguzzardiM @gyncsm We'll have to check the full results about that specifically. I know I could talk about #clinicaltrials all day. We have done several chats on different aspects but always seems there is more to talk about. #gyncsm
Rachel Pozzar, PhD, RN @RPozzar
@womenofteal @gyncsm Researcher and NP here, following tonight’s chat. Thanks, @womenofteal and @btrfly12 for all you do. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
For the rest of the time tonight we offer you, our participants, the "mic". You are free to ask ?ʼs, make comments, share advice and to share your story. #gyncsm
Tobey @BRCAinfo
I’m really sorry I will have to catch up with your transcript tomorrow - I just got a call from a friend in need. Happy & healthy holidays everyone #gyncsm
Dee Sparacio @womenofteal
@LguzzardiM @gyncsm 88% rated side effects as most important , 66% for clinical trials so it would fall at number 9 or 10 in our list. #gyncsm
Dee Sparacio @womenofteal
RT @btrfly12: Thanks so much to everyone who filled out the survey. We are using the topic feedback as we finalize our 2020 chats. FYI - We'll be taking off March/June/October as we did in 2019. #gyncsm
Jillosopher, BSN, RN @jillosopher
@RPozzar @womenofteal @gyncsm @btrfly12 Hi Rachel! I'm a new (but old) RN. Career change thing. #gyncsm
Tanya Temkin @tanyaltee
One big issue I’ve heard from many OC survivors is how to get into a trial— Phase 3 especially. Apparently very competitive #gyncsm
Dee Sparacio @womenofteal
@RPozzar @gyncsm @btrfly12 Hi Rachel , Thanks for joining our chat tonight. #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: For the rest of the time tonight we offer you, our participants, the "mic". You are free to ask ?ʼs, make comments, share advice and to share your story. #gyncsm
Christina Lizaso @btrfly12
@BRCAinfo So glad to tweet along with you for a bit. You are such a wonderful support for others. Happy Holidays. #gyncsm
Christina Lizaso @btrfly12
RT @tanyaltee: One big issue I’ve heard from many OC survivors is how to get into a trial— Phase 3 especially. Apparently very competitive #gyncsm
Jillosopher, BSN, RN @jillosopher
@BRCAinfo Take care, Tobey, and happy holidays to you, too. #gyncsm
Sarah Temkin @temkins
Sorry I'm late! Happy holidays and amazing survey #gyncsm
Rick Boulay,MD @journeycancer
You can find all the clinical trials open in the country on https://t.co/Qq5P2ZzYcW. You can search under ovarian cancer. Or often times your local health networks will have them on their website. #gyncsm
Jillosopher, BSN, RN @jillosopher
@temkins Hi Sarah! #gyncsm Happy holidays to you.
Dee Sparacio @womenofteal
@temkins Hi Sarah, Good to see you. #gyncsm
Dee Sparacio @womenofteal
RT @journeycancer: You can find all the clinical trials open in the country on https://t.co/Qq5P2ZzYcW. You can search under ovarian cancer. Or often times your local health networks will have them on their website. #gyncsm
Christina Lizaso @btrfly12
Clinical trials are tough as each one is so different and finding even the right contact person at each site is a challenge. @power4patients and others have good resource collections but still daunting https://t.co/VAzeMMGbb5 #gyncsm
Tanya Temkin @tanyaltee
@temkins Hi Sarah, from the other Temkin! #gyncsm
Christina Lizaso @btrfly12
RT @journeycancer: You can find all the clinical trials open in the country on https://t.co/Qq5P2ZzYcW. You can search under ovarian cancer. Or often times your local health networks will have them on their website. #gyncsm
Amanda Crowell Itliong @MIShouldTalk
Hey everybody! I’ve been thinking about this article and study today. #gyncsm
Dee Sparacio @womenofteal
You would think that being moderator for 6 yrs I would remember to use the #gyncsm hashtag.
Dee Sparacio @womenofteal
RT @btrfly12: Clinical trials are tough as each one is so different and finding even the right contact person at each site is a challenge. @power4patients and others have good resource collections but still daunting https://t.co/VAzeMMGbb5 #gyncsm
Christine (Cissy) White @healWRITEnow
@tanyaltee #gyncsm Is it based on location, I wonder, or other factors about age, stage, and treatment? I wonder if that will change when a PARBs more readily available earlier no matter what BRCA status?
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
It still seems that minority pops are overlooked in clinical trials, yet the data from these groups is crucial. Minority participation still stand at around 4%, well below the national averages. Why is this? #gyncsm
Christina Lizaso @btrfly12
A huge thank you to our healthcare professionals. You give so much of yourselves to your patients and we appreciate your time on #gyncsm
Christina Lizaso @btrfly12
RT @ShereesePubHlth: It still seems that minority pops are overlooked in clinical trials, yet the data from these groups is crucial. Minority participation still stand at around 4%, well below the national averages. Why is this? #gyncsm
Dee Sparacio @womenofteal
@MIShouldTalk Hi Amanda , I have thought about those results too. I had surgery on recurrence. #gyncsm
Christina Lizaso @btrfly12
RT @womenofteal: You would think that being moderator for 6 yrs I would remember to use the #gyncsm hashtag.
Dee Sparacio @womenofteal
RT @ShereesePubHlth: It still seems that minority pops are overlooked in clinical trials, yet the data from these groups is crucial. Minority participation still stand at around 4%, well below the national averages. Why is this? #gyncsm
Jillosopher, BSN, RN @jillosopher
@MIShouldTalk That's disheartening. I'll have to read it later. I wonder if that conclusion applies to all cell types and grades of ovca. #gyncsm
Tanya Temkin @tanyaltee
Women get frustrated by exclusion criteria too. Very disheartening for those who feel they’ve run out of options. #gyncsm
Christina Lizaso @btrfly12
@MIShouldTalk Here's the study link directly... hmmm Surgery for Recurrent Ovarian Cancer Does Not Improve Survival https://t.co/dERUkEI0Kp #gyncsm
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
RT @btrfly12: @MIShouldTalk Here's the study link directly... hmmm Surgery for Recurrent Ovarian Cancer Does Not Improve Survival https://t.co/dERUkEI0Kp #gyncsm
Dee Sparacio @womenofteal
@ShereesePubHlth That's a great question. My cancer center just opened a Health Disparities center to try to understand and increase numbers of minorities who participate. As for why - I'll start with Language barriers, travel, child care, #gyncsm
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
RT @womenofteal: @ShereesePubHlth That's a great question. My cancer center just opened a Health Disparities center to try to understand and increase numbers of minorities who participate. As for why - I'll start with Language barriers, travel, child care, #gyncsm
Dee Sparacio @womenofteal
I agree 100% .
Christina Lizaso @btrfly12
@ShereesePubHlth Are there any national organizations with specific initiatives in this area - minority participation in #clinicaltrials ? #gyncsm
Sarah Temkin @temkins
Black and Hispanic women are definitely under-accrued to clinical trials in ovarian cancer but this disparity is less pronounced in endometrial and cervical cancer #gyncsm https://t.co/vljBh6hCWv
Christina Lizaso @btrfly12
RT @tanyaltee: Women get frustrated by exclusion criteria too. Very disheartening for those who feel they’ve run out of options. #gyncsm
Christina Lizaso @btrfly12
RT @womenofteal: @ShereesePubHlth That's a great question. My cancer center just opened a Health Disparities center to try to understand and increase numbers of minorities who participate. As for why - I'll start with Language barriers, travel, child care, #gyncsm
Christina Lizaso @btrfly12
RT @temkins: Black and Hispanic women are definitely under-accrued to clinical trials in ovarian cancer but this disparity is less pronounced in endometrial and cervical cancer #gyncsm https://t.co/vljBh6hCWv
Rick Boulay,MD @journeycancer
That question has been explored quite a bit. There are a number of findings. The first is language barriers make it difficult to explain studies to nonEnglish speaking people. The second are cultural barriers formed by mistrust of The medical establishment. #gyncsm
Sarah Temkin @temkins
@btrfly12 @ShereesePubHlth @ECANAwomen and @KemiDoll are all over this in endometrial cancer. #gyncsm.
Dee Sparacio @womenofteal
@jillosopher @MIShouldTalk I believe it was HGSOC. We already knew that more than 1-3 spots should not have surgery yet some patients had surgery in the study and not all the cancer was removed. That could explain the results. #gyncsm
Dee Sparacio @womenofteal
RT @tanyaltee: Women get frustrated by exclusion criteria too. Very disheartening for those who feel they’ve run out of options. #gyncsm
Dee Sparacio @womenofteal
RT @temkins: Black and Hispanic women are definitely under-accrued to clinical trials in ovarian cancer but this disparity is less pronounced in endometrial and cervical cancer #gyncsm https://t.co/vljBh6hCWv
Dee Sparacio @womenofteal
RT @btrfly12: @MIShouldTalk Here's the study link directly... hmmm Surgery for Recurrent Ovarian Cancer Does Not Improve Survival https://t.co/dERUkEI0Kp #gyncsm
Dee Sparacio @womenofteal
RT @journeycancer: That question has been explored quite a bit. There are a number of findings. The first is language barriers make it difficult to explain studies to nonEnglish speaking people. The second are cultural barriers formed by mistrust of The medical establishment. #gyncsm
Lisa M Guzzardi, RN @LguzzardiM
Helping Cancer Patients Navigate #ClinicalTrials #gyncsm #ovariancancer Via ⁦@biospacehttps://t.co/EoqjWTXZYA
Sarah Temkin @temkins
RT @LguzzardiM: Helping Cancer Patients Navigate #ClinicalTrials #gyncsm #ovariancancer Via ⁦@biospacehttps://t.co/EoqjWTXZYA
Christine (Cissy) White @healWRITEnow
@journeycancer #gyncsm Wow. I wonder about representation among medical offices and teams & if that is a factor re: language, recruitment, trust, safety?
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
Those are some real issues, especially the issue of trust. But that places a lot of the ownership on the populations, not the industry. I'd include the fact that clinical trial orgs often use the old pipelines for trials & are not inclusive and they need to be. #gyncsm
Jillosopher, BSN, RN @jillosopher
#gyncsm
Christina Lizaso @btrfly12
Research and ovarian cancer advocate @Stigetta was involved in this paper that just came out: A Priorities Assessment Tool to Support Shared Decision Making, Maximize Appointment Time, and Increase Patient Satisfaction in Women With Ovarian Cancer https://t.co/8WJzSdXcPn #gyncsm
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
RT @btrfly12: Research and ovarian cancer advocate @Stigetta was involved in this paper that just came out: A Priorities Assessment Tool to Support Shared Decision Making, Maximize Appointment Time, and Increase Patient Satisfaction in Women With Ovarian Cancer https://t.co/8WJzSdXcPn #gyncsm
Rick Boulay,MD @journeycancer
That is absolutely true. We hired bilingual clinical trials nurses and immediately begin accruing non-English speakers. You have to know your community and support it. #GYNCSM
Dee Sparacio @womenofteal
@temkins This article talks about the rising numbers of black women with endometrial cancer / uterine sarcoma a #gyncsm https://t.co/55lqvidkE2
Christina Lizaso @btrfly12
RT @healWRITEnow: @journeycancer #gyncsm Wow. I wonder about representation among medical offices and teams & if that is a factor re: @journeycancer #gyncsm Wow. I wonder about representation among medical offices and teams & if that is a factor re: language, recruitment, trust, safety?
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
RT @womenofteal: @temkins This article talks about the rising numbers of black women with endometrial cancer / uterine sarcoma a #gyncsm https://t.co/55lqvidkE2
Dee Sparacio @womenofteal
RT @LguzzardiM: Helping Cancer Patients Navigate #ClinicalTrials #gyncsm #ovariancancer Via ⁦@biospacehttps://t.co/EoqjWTXZYA
Christina Lizaso @btrfly12
RT @journeycancer: That is absolutely true. We hired bilingual clinical trials nurses and immediately begin accruing non-English speakers. You have to know your community and support it. #GYNCSM
Dee Sparacio @womenofteal
RT @ShereesePubHlth: Those are some real issues, especially the issue of trust. But that places a lot of the ownership on the populations, not the industry. I'd include the fact that clinical trial orgs often use the old pipelines for trials & are not inclusive and they need to be. #gyncsm
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
Enrollment of Racial Minorities in Clinical Trials: Old Problem Assumes New Urgency in the Age of Immunotherapy | American Society of Clinical Oncology Educational Book https://t.co/V3mJeux84d #gyncsm
Dee Sparacio @womenofteal
RT @jillosopher: #gyncsm
Dee Sparacio @womenofteal
RT @btrfly12: Research and ovarian cancer advocate @Stigetta was involved in this paper that just came out: A Priorities Assessment Tool to Support Shared Decision Making, Maximize Appointment Time, and Increase Patient Satisfaction in Women With Ovarian Cancer https://t.co/8WJzSdXcPn #gyncsm
Sarah Temkin @temkins
RT @womenofteal: @temkins This article talks about the rising numbers of black women with endometrial cancer / uterine sarcoma a #gyncsm https://t.co/55lqvidkE2
Sarah Temkin @temkins
RT @ShereesePubHlth: Enrollment of Racial Minorities in Clinical Trials: Enrollment of Racial Minorities in Clinical Trials: Old Problem Assumes New Urgency in the Age of Immunotherapy | American Society of Clinical Oncology Educational Book https://t.co/V3mJeux84d #gyncsm
Christina Lizaso @btrfly12
@LguzzardiM @biospace Clinical trial navigation is a big need. #gyncsm
Dee Sparacio @womenofteal
@btrfly12 @Stigetta This is awesome work and hopefully the survey can have widespread implementation. #gyncsm
Dee Sparacio @womenofteal
RT @journeycancer: That is absolutely true. We hired bilingual clinical trials nurses and immediately begin accruing non-English speakers. You have to know your community and support it. #GYNCSM
Rick Boulay,MD @journeycancer
@ShereesePubHlth I believe the trust issue is expressly the result of unethical clinical trials performed at the expense of subjects in minority communities, specifically African-American. Those of us who currently perform clinical trials need to earn that trust back. #GYNCSM
Dee Sparacio @womenofteal
RT @ShereesePubHlth: Enrollment of Racial Minorities in Clinical Trials: Enrollment of Racial Minorities in Clinical Trials: Old Problem Assumes New Urgency in the Age of Immunotherapy | American Society of Clinical Oncology Educational Book https://t.co/V3mJeux84d #gyncsm
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
RT @journeycancer: @ShereesePubHlth I believe the trust issue is expressly the result of unethical clinical trials performed at the expense of subjects in minority communities, specifically African-American. Those of us who currently perform clinical trials need to earn that trust back. #GYNCSM
Dee Sparacio @womenofteal
RT @journeycancer: @ShereesePubHlth I believe the trust issue is expressly the result of unethical clinical trials performed at the expense of subjects in minority communities, specifically African-American. Those of us who currently perform clinical trials need to earn that trust back. #GYNCSM
Dee Sparacio @womenofteal
Did you see this Nature article: Both fallopian tube & ovarian surface epithelium are cells-of-origin for HGSOC https://t.co/4rhbkfzNNl #gyncsm
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
RT @womenofteal: Did you see this Nature article: Did you see this Nature article: Both fallopian tube & ovarian surface epithelium are cells-of-origin for HGSOC https://t.co/4rhbkfzNNl #gyncsm
Christina Lizaso @btrfly12
#gyncsm
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
RT @btrfly12: #gyncsm
Jillosopher, BSN, RN @jillosopher
@ShereesePubHlth Can't wait to read that! #gyncsm
Dee Sparacio @womenofteal
@btrfly12 Great minds think alike . LOL #gyncsm
Dee Sparacio @womenofteal
#gyncsm
GYN Cancer | #GYNCSM @gyncsm
Thanks to all who have joined along for tonight's #gyncsm chat. We like to take time at the end to share any closing thoughts and use TIL: at the start of the tweet to stand for Today I Learned. You can also share any initiatives/blog posts/announcements.
Dee Sparacio @womenofteal
#gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: Thanks to all who have joined along for tonight's #gyncsm chat. We like to take time at the end to share any closing thoughts and use TIL: at the start of the tweet to stand for Today I Learned. You can also share any initiatives/blog posts/announcements.
Christina Lizaso @btrfly12
Dee has some great thoughts on the getting through the holidays while in treatment. Check out her post on @Globeathon https://t.co/bqOfUZMnLb #gyncsm
Christina Lizaso @btrfly12
RT @womenofteal: #gyncsm
Rick Boulay,MD @journeycancer
RT @btrfly12: Dee has some great thoughts on the getting through the holidays while in treatment. Check out her post on @Globeathon https://t.co/bqOfUZMnLb #gyncsm
Tanya Temkin @tanyaltee
@womenofteal So many articles linked in this chat for me to review and introduce to the FB OVCA support groups I take part in... #gyncsm
Jillosopher, BSN, RN @jillosopher
RT @btrfly12: Dee has some great thoughts on the getting through the holidays while in treatment. Check out her post on @Globeathon https://t.co/bqOfUZMnLb #gyncsm
Jillosopher, BSN, RN @jillosopher
RT @LguzzardiM: Helping Cancer Patients Navigate #ClinicalTrials #gyncsm #ovariancancer Via ⁦@biospacehttps://t.co/EoqjWTXZYA
Dee Sparacio @womenofteal
@tanyaltee See you in those groups Tanya. I'll post the links to the studies in our blog post too in case you need to refer back to them. #gyncsm
Christine (Cissy) White @healWRITEnow
@tanyaltee @womenofteal #gyncsm what’s the FB group?
Christina Lizaso @btrfly12
TIL: So thankful to spend time each month on #gyncsm. Thankful for all each one of you does as an advocate for yourself and others impacted by cancer. Enjoyed seeing both new and familiar faces for our "less formal" chat to close out the year. Best wishes to all in 2020.
GYN Cancer | #GYNCSM @gyncsm
Thanks to everyone for the wonderful conversation. Please join us in January - one week later than usual - on Wednesday Jan 15th for our chat about “Goals of Care throughout the Cancer Experience” #gyncsm
Dee Sparacio @womenofteal
I am so grateful to all the survey participants for letting us know what we are doing right and what we can improve on. TIL we can support one another by sharing information . #gyncsm
Rick Boulay,MD @journeycancer
TIL Our advocates continue to push the clinical medical practitioners and researchers to be better in every way. Thank you all for showing us the way. #gyncsm
Jillosopher, BSN, RN @jillosopher
Not #gyncsm related, but wanted to share that I lost my best friend to breast cancer one month ago. I feel grief, fear about myself, survivor guilt, and did I mention fear about myself as I come up on 3 yrs post dx? R.I.P. Pilar.
Christina Lizaso @btrfly12
RT @journeycancer: TIL Our advocates continue to push the clinical medical practitioners and researchers to be better in every way. Thank you all for showing us the way. #gyncsm
Dee Sparacio @womenofteal
@healWRITEnow @tanyaltee There are a number of closed Facebook groups that OC can join. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
As always, remember to tweet things of interest with hashtag #gyncsm to keep the conversation going between chats.
Jillosopher, BSN, RN @jillosopher
RT @gyncsm: Thanks to everyone for the wonderful conversation. Please join us in January - one week later than usual - on Wednesday Jan 15th for our chat about “Goals of Care throughout the Cancer Experience” #gyncsm
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
Have a safe and peaceful season. #gyncsm https://t.co/vT9QHMdULW
Rick Boulay,MD @journeycancer
Here’s to an amazing 2020! Your next year of survivorship! Have a wonderful holiday everyone. #gyncsm
Dee Sparacio @womenofteal
@jillosopher So sorry for your loss. I know I lost a friend , fellow advocate and non-profit OC foundation founder last week. Difficult times for sure. #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: As always, remember to tweet things of interest with hashtag #gyncsm to keep the conversation going between chats.
Dee Sparacio @womenofteal
Wishing everyone a very Happy Holidays #gyncsm https://t.co/xCFs7bOIiu
Christina Lizaso @btrfly12
Thankful for all the good, hard work @womenofteal does on our blog. I think the chat summaries are such a great resource. Also for keeping things on track and laying out great topics. Here's to another year. #gyncsm
Christina Lizaso @btrfly12
RT @womenofteal: Wishing everyone a very Happy Holidays #gyncsm https://t.co/xCFs7bOIiu
Dee Sparacio @womenofteal
Remember to check https://t.co/Df2f7Okp35 for a transcript of the chat and resources #gyncsm
Christine (Cissy) White @healWRITEnow
RT @btrfly12: TIL: TIL: So thankful to spend time each month on #gyncsm. Thankful for all each one of you does as an advocate for yourself and others impacted by cancer. Enjoyed seeing both new and familiar faces for our "less formal" chat to close out the year. Best wishes to all in 2020.
Tanya Temkin @tanyaltee
@healWRITEnow @womenofteal There are several... Sisterhood of Ovarian Cancer Survivors, Ovarian Cancer Support Group among other closed groups. #gyncsm
Jillosopher, BSN, RN @jillosopher
@womenofteal Oh no, so sorry, Dee. #gyncsm
Dee Sparacio @womenofteal
@btrfly12 Thanks! I could never do this without you. Thanks for being the best partner I could ever ask for. #gyncsm
Sarah Temkin @temkins
RT @womenofteal: Remember to check https://t.co/Df2f7Okp35 for a transcript of the chat and resources #gyncsm
Christina Lizaso @btrfly12
@jillosopher Thanks for sharing and so sorry for your loss. Cancer takes so much. Some days are especially hard. #gyncsm
Sarah Temkin @temkins
RT @journeycancer: TIL Our advocates continue to push the clinical medical practitioners and researchers to be better in every way. Thank you all for showing us the way. #gyncsm
Dee Sparacio @womenofteal
@journeycancer Same to you Rick. #gyncsm
Jillosopher, BSN, RN @jillosopher
@btrfly12 @womenofteal Thanks, Christina! You and Dee do such a great job. I appreciate you both so much. #gyncsm
Jillosopher, BSN, RN @jillosopher
@ShereesePubHlth Happy holidays, Shereese! #gyncsm
Dee Sparacio @womenofteal
Thanks @jillosopher @tanyaltee @ShereesePubHlth @healWRITEnow for joining us tonight. See you in the new year. #gyncsm
Tanya Temkin @tanyaltee
Talk & tweet with you all in the New Year. Have wonderful holidays! #gyncsm
Rick Boulay,MD @journeycancer
Thank you Dee and Christina for all you do for The GYN oncology community. #gyncsm
Jillosopher, BSN, RN @jillosopher
@womenofteal @tanyaltee @ShereesePubHlth @healWRITEnow Happy holidays to all. #gyncsm
Dee Sparacio @womenofteal
@ShereesePubHlth You too. #gyncsm
Jillosopher, BSN, RN @jillosopher
Goodnight #gyncsm community. Wishing all a happy and healthy holiday season.
Anthony M Tucker @AnthonyCFO
RT @ShereesePubHlth: Enrollment of Racial Minorities in Clinical Trials: Enrollment of Racial Minorities in Clinical Trials: Old Problem Assumes New Urgency in the Age of Immunotherapy | American Society of Clinical Oncology Educational Book https://t.co/V3mJeux84d #gyncsm
Anthony M Tucker @AnthonyCFO
RT @ShereesePubHlth: It still seems that minority pops are overlooked in clinical trials, yet the data from these groups is crucial. Minority participation still stand at around 4%, well below the national averages. Why is this? #gyncsm
Dee Sparacio @womenofteal
@healWRITEnow Missed this in my flurry of notifications. Yes, you may use #gyncsm for any gyn cancer - endometrial, uterine sarcoma , cervical, vulvar, vaginal, fallopian tube as well as primary peritoneal and GTD.
Jillosopher, BSN, RN @jillosopher
RT @womenofteal: @healWRITEnow Missed this in my flurry of notifications. Yes, you may use #gyncsm for any gyn cancer - endometrial, uterine sarcoma , cervical, vulvar, vaginal, fallopian tube as well as primary peritoneal and GTD.
#GynCSM content from Twitter.